Chronic Low Back Pain clinical trials

Explore recruiting chronic low back pain clinical trials.

Recruiting chronic low back pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Low Back Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2, multicenter, randomized, double blind, active controlled, parallel group study assessing the analgesic effect and safety of two doses of DFL24412 in patients with chronic low back pain compared to Ketoprofen Lysine Salt (KLS)

Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Melatonin for patients with chronic low back pain (MELBACK) - a randomized placebo-controlled trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of antibiotic treatment for patients with chronic low back pain and Modic type I changes - randomized placebo-controlled trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Pain medication tapering for chronic low back pain patients, treated with an intervention focusing on pain relief for axial problems.

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

A double blind, double dummy, multicenter, randomized, placebo- and active-controlled clinical trial to evaluate effectiveness of Tricortin 1000 in patients affected by chronic low back pain

Italy

Therapeutic use (Phase IV) EU CTIS Study details

J1I-MC-GZQD: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain (TRIUMPH-7)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Low Back Pain trials by city

Chronic Low Back Pain in Toronto Chronic Low Back Pain in Vancouver Chronic Low Back Pain in Montreal Chronic Low Back Pain in Calgary Chronic Low Back Pain in Edmonton Chronic Low Back Pain in Ottawa Chronic Low Back Pain in Winnipeg Chronic Low Back Pain in Quebec City Chronic Low Back Pain in Hamilton Chronic Low Back Pain in Kitchener Chronic Low Back Pain in London Chronic Low Back Pain in Halifax Chronic Low Back Pain in New York Chronic Low Back Pain in Los Angeles Chronic Low Back Pain in Chicago Chronic Low Back Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease